Skip to content

Intervention study to develop a technique to detect reversible brain fatigue (electronic screen syndrome) by electronic screen using EEG measurement

Intervention study to develop a technique to detect reversible brain fatigue (electronic screen syndrome) by electronic screen using EEG measurement - Intervention study to develop a technique to detect reversible brain fatigue (electronic screen syndrome) by electronic screen using EEG measurement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053781
Enrollment
30
Registered
2024-03-05
Start date
2023-06-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

Sponsors

Rohto Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adults aged between 18 and 60 at the time of obtaining consent 2) Those who have received sufficient explanation about the purpose and contents of this research, have the ability to consent, voluntarily apply for participation after understanding it well, and can consent to participate in this research in writing. 3) Those who use smartphones frequently (more than 2 hours a day on average for screen time) 4) Those who can come to the measurement venue 2-3 times in total for the measurement

Exclusion criteria

Exclusion criteria: 1) Those who have changed or newly started using health food habitually taken within the past 4 weeks 2) Those who work night shift or day and night shift system 3) Those who are undergoing treatment (hormone replacement therapy, drug therapy, exercise therapy, diet therapy, etc.) at medical institutions for the treatment or prevention of disease, or those who are judged to be in need of treatment. 4) Subjects with a history of diagnosis of serious diseases of glucose metabolism, lipid metabolism, liver function, renal function, heart, circulatory system, respiratory system, endocrine system, immune system nervous system, or mental disease. 5) Those who have a history of alcohol dependence or drug dependence 6) Those who are pregnant, breastfeeding, or wish to become pregnant while participating in the study 7) Participated in other human studies (human studies using foods, drugs, quasi-drugs, medical devices, etc.) within the past 4 weeks, or other studies during the scheduled period of this study plan to participate in a human trial

Design outcomes

Primary

MeasureTime frame
Detection of EEG features with and without electronic screen

Countries

Japan

Contacts

Public ContactEIKO UNO

Rohto Pharmaceutical Co., Ltd. Basic Research and Development Division

unoe@rohto.co.jp0774718773

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026